X
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): TDI01
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: TDI01
Highest Development Status: Phase I Product Type: Small molecule
Partner/Sponsor/Collaborator: Graviton
Deal Size: $517.5 million Upfront Cash: Undisclosed
Deal Type: Licensing Agreement February 23, 2021
Details:
The agreement grants development and commercialization rights for TDI01 to Graviton in all territories, excluding China.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
